miércoles, 12 de enero de 2022

NCA - Monoclonal Antibodies Directed Against Amyloid for the Treatment of Alzheimer’s Disease (CAG-00460N) - Proposed Decision Memo

NCA - Monoclonal Antibodies Directed Against Amyloid for the Treatment of Alzheimer’s Disease (CAG-00460N) - Proposed Decision Memo

No hay comentarios: